BIOMARKER:

ALK G1202R

Entrez ID:

Related biomarkers:

‹

›

ALK G1202R ALK G1202R	Non Small Cell Lung Cancer NSCLC	ALK G1202R ALK G1202R	Non Small Cell Lung Cancer NSCLC	lorlatinib Sensitive: A2 - Guideline	lorlatinib Sensitive: A2 - Guideline
ALK G1202R ALK G1202R	Non Small Cell Lung Cancer NSCLC	ALK G1202R ALK G1202R	Non Small Cell Lung Cancer NSCLC	alectinib Resistant: C3 – Early Trials	alectinib Resistant: C3 – Early Trials
ALK G1202R ALK G1202R	Non Small Cell Lung Cancer NSCLC	ALK G1202R ALK G1202R	Non Small Cell Lung Cancer NSCLC	ensartinib Resistant: C3 – Early Trials	ensartinib Resistant: C3 – Early Trials
ALK G1202R ALK G1202R	Non Small Cell Lung Cancer NSCLC	ALK G1202R ALK G1202R	Non Small Cell Lung Cancer NSCLC	ceritinib Resistant: C3 – Early Trials	ceritinib Resistant: C3 – Early Trials
ALK G1202R ALK G1202R	Non Small Cell Lung Cancer NSCLC	ALK G1202R ALK G1202R	Non Small Cell Lung Cancer NSCLC	crizotinib Resistant: C3 – Early Trials	crizotinib Resistant: C3 – Early Trials
ALK G1202R ALK G1202R	Non Small Cell Lung Cancer NSCLC	ALK G1202R ALK G1202R	Non Small Cell Lung Cancer NSCLC	brigatinib Sensitive: C4 – Case Studies	brigatinib Sensitive: C4 – Case Studies